MDxHealth Statistics

Total Valuation

MDxHealth has a market cap or net worth of $21.92 million. The enterprise value is $84.65 million.

Market Cap	21.92M
Enterprise Value	84.65M

Important Dates

The next estimated earnings date is Tuesday, August 4, 2026, after market close.

Earnings Date	Aug 4, 2026
Ex-Dividend Date	n/a

Share Statistics

MDxHealth has 51.36 million shares outstanding. The number of shares has increased by 33.51% in one year.

Current Share Class	51.36M
Shares Outstanding	51.36M
Shares Change (YoY)	+33.51%
Shares Change (QoQ)	-0.68%
Owned by Insiders (%)	6.46%
Owned by Institutions (%)	29.17%
Float	35.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.20
Forward PS	0.20
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.63

Current Ratio	1.63
Quick Ratio	1.38
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.11

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-6.38%
Return on Invested Capital (ROIC)	-12.19%
Return on Capital Employed (ROCE)	-14.36%
Weighted Average Cost of Capital (WACC)	-478,120.09%
Revenue Per Employee	$304,860
Profits Per Employee	-$91,146
Employee Count	364
Asset Turnover	0.66
Inventory Turnover	7.52

Taxes

Income Tax	-1.99M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.86% in the last 52 weeks. The beta is -506,809.90, so MDxHealth's price volatility has been lower than the market average.

Beta (5Y)	-506,809.90
52-Week Price Change	-80.86%
50-Day Moving Average	1.22
200-Day Moving Average	3.02
Relative Strength Index (RSI)	18.91
Average Volume (20 Days)	814,429

Short Selling Information

The latest short interest is 457,830, so 1.18% of the outstanding shares have been sold short.

Short Interest	457,830
Short Previous Month	910,289
Short % of Shares Out	1.18%
Short % of Float	n/a
Short Ratio (days to cover)	0.40

Income Statement

In the last 12 months, MDxHealth had revenue of $110.97 million and -$33.18 million in losses. Loss per share was -$0.65.

Revenue	110.97M
Gross Profit	70.74M
Operating Income	-17.12M
Pretax Income	-35.17M
Net Income	-33.18M
EBITDA	-10.72M
EBIT	-17.12M
Loss Per Share	-$0.65

Full Income Statement

Balance Sheet

The company has $43.15 million in cash and $105.88 million in debt, giving a net cash position of -$62.73 million or -$1.22 per share.

Cash & Cash Equivalents	43.15M
Total Debt	105.88M
Net Cash	-62.73M
Net Cash Per Share	-$1.22
Equity (Book Value)	-20.23M
Book Value Per Share	-0.39
Working Capital	26.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.05 million and capital expenditures -$1.04 million, giving a free cash flow of -$2.09 million.

Operating Cash Flow	-1.05M
Capital Expenditures	-1.04M
Depreciation & Amortization	6.40M
Net Borrowing	16.74M
Free Cash Flow	-2.09M
FCF Per Share	-$0.04

Full Cash Flow Statement

Margins

Gross margin is 63.75%, with operating and profit margins of -15.43% and -29.90%.

Gross Margin	63.75%
Operating Margin	-15.43%
Pretax Margin	-31.69%
Profit Margin	-29.90%
EBITDA Margin	-9.66%
EBIT Margin	-15.43%
FCF Margin	n/a

Dividends & Yields

MDxHealth does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.51%
Shareholder Yield	-33.51%
Earnings Yield	-151.34%
FCF Yield	-9.54%

Analyst Forecast

The average price target for MDxHealth is $2.90, which is 579.48% higher than the current price. The consensus rating is "Buy".

Price Target	$2.90
Price Target Difference	579.48%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (3Y)	8.42%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date	Nov 14, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

MDxHealth has an Altman Z-Score of -2.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.54
Piotroski F-Score	3